23 sales executive equipment jobs found

This is a field-based position, and candidates should reside within a reasonable distance of a major airport and may live outside of the posted city and state. This role supports teams located in Maine, New Hampshire, Vermont, Massachusetts, Rhode Island, Connecticut, New York, New Jersey, Pennsylvania, Delaware, Maryland, Virginia, North Carolina, South Carolina, Georgia, Florida, Ohio, West Virginia, Kentucky, Tennessee, Alabama, and Mississippi. The Senior Manager, Psychiatry Account Executives, leads, coaches and develops a regional team of Psychiatry Account Executives (PAEs). Reporting directly to the Director of the PAE national team, the primary objective of this role includes assessing regional business opportunities across priority Behavioral Health Accounts (including IDNs, Hospitals, Community Mental Health Centers, VA) to achieve assigned product performance goals and drive growth in the atypical antipsychotic market. Effective execution within target accounts and...

This is a field-based position, and candidates should reside within a reasonable distance of a major airport and may live outside of the posted city and state. This role supports teams located in Washington, Oregon, California, Idaho, Nevada, Montana, Wyoming, Utah, Colorado, Arizona, New Mexico, Alaska, Hawaii, Texas, Oklahoma, Kansas, Nebraska, South Dakota, North Dakota, Minnesota, Iowa, Missouri, Arkansas, and Louisiana. The Senior Manager, Psychiatry Account Executives, leads, coaches and develops a regional team of Psychiatry Account Executives (PAEs). Reporting directly to the Director of the PAE national team, the primary objective of this role includes assessing regional business opportunities across priority Behavioral Health Accounts (including IDNs, Hospitals, Community Mental Health Centers, VA) to achieve assigned product performance goals and drive growth in the atypical antipsychotic market. Effective execution within target accounts and with key customer...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was granted accelerated approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults with NASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) and is being studied in a Phase 3 trial for the treatment of NASH with compensated cirrhosis. Position Summary The Executive Director of Commercial Data Strategy and Analytics will be a senior leader responsible for building and scaling Madrigal’s global commercial data ecosystem. This role will own the commercial data vision and analytics roadmap in the short and long-term to enable Rezdiffra’s trajectory to peak performance, while also laying the foundation for future product launches. The role includes oversight of the commercial analytics team,...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

This position requires candidates to be field-based and to reside within the specified geography, which includes Delaware, District of Columbia, Virginia, Maryland, West Virginia, North Carolina, South Carolina, Georgia, Florida, Alabama, Tennessee, Mississippi, Kentucky, Indiana, Illinois, Missouri, Louisiana, Arkansas, and Texas. Additionally, candidates must live within a commutable distance to a major airport within this region. The Neuroscience Regional Sales Director leads the sales performance and professional development of a team of District Managers and Account Specialists covering the West Region.  Core areas of focus are Chronic Migraine, Focal Spasticity and Cervical Dystonia indications. The sales team supports customers in community/private practices, community-based hospitals, academic medical centers, military treatment facilities, and Veteran’s Affairs Medical Centers. Called on providers primarily include Neurologists, Physiatrists, but also non-specialist and...

Job Title Regional Sales Leader -Ultrasound General Imaging (West Region) Job Description Regional Sales Leader -Ultrasound General Imaging (West Region) The District Sales Leader -Ultrasound General Imaging (West) is responsible for leading sales and commercial partnerships, developing sales strategies and forecasts, managing Account Managers, ensuring financial and performance targets are met, fostering customer relationships, overseeing sales promotions, and directing talent management to drive revenue growth and market expansion. The role ensures targets for sales, volume, and financial performance are met through strategic performance management and budget control. Your role: Leads sales and commercial partnerships with customers in the West Region, oversees a diverse product portfolio to drive revenue growth and optimizes market penetration. Develop sales and distribution strategy and sales plan, including detailed sales forecasts and Annual Operating Plan...

Global Marketing Director Job Title: Global Marketing Director Job Type: Full-time Travel: 20-30% Global Location: US (San Diego, CA Preferred) Why Join Our Client: Launch a breakthrough surgical robotic platform Build a marketing organization from the ground up Shape the future of cranial surgery Work in a culture that values speed, ownership, and impact Grow into VP / Global leadership as they scale This is a career-defining role for someone who wants to lead, build, and win. About Our Client: Our Client is a global leader in robotics and AI-based measurement, trusted across advanced manufacturing, aerospace, semiconductor, and life sciences. With over 3,500 robotic systems deployed globally, we bring proven engineering scale and discipline to surgical innovation. Our medical division is launching an intelligent cranial robotic navigation system designed to help neurosurgeons achieve exceptional precision and...

Job Title Regional Sales Director- Diagnostic Imaging (West) Job Description Regional Sales Director- Diagnostic Imaging (West) As a Regional Sales Director- Diagnostic Imaging (West) you will drive the Imaging business to secure profitable growth in line with our annual objectives and targets. You are responsible for growing Philips Imaging market share within an assigned Region. You will work at all levels within customer accounts (C-Suite, Department level, Purchasing) to effectively position Philips, and drive the strategy to grow win-rate and order intake for DXR, CT, and MR modality businesses. Your role: Increase market share growth and visibility across the Imaging portfolio (DXR, CT, and MR) and increase win rate while leading accurate Forecasting with achievement of business-specific financial goals. Lead team of Imaging Account Specialists, with clear expectation setting, regular communication, accountability, and succession planning.  Ensure the team is...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries.       JOB DESCRIPTION: A healthy heart is essential to good health. That's why we're committed to advancing treatments for people with cardiovascular disease. As a global leader in Cardiac Rhythm Technologies, our breakthrough medical technologies help restore people's health so they can get back to living their best lives, faster. We focus on innovative technologies that can improve the way doctors treat people with heart arrhythmias, or irregular heartbeats. Working at Abbott At Abbott, you can do work that matters, grow, and learn, care for yourself and your family, be your true self, and live a full life. You’ll also have...

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries.       JOB DESCRIPTION: Working at Abbott At Abbott, you can do work that matters, grow, and learn, care for yourself and family, be your true self and live a full life. You’ll also have access to: Career development with an international company where you can grow the career you dream of Employees can qualify for free medical coverage in our Health Investment Plan (HIP) PPO medical plan in the next calendar year An excellent retirement savings plan with high employer contribution Tuition reimbursement, the Freedom 2 Save student debt program and FreeU education benefit - an affordable and convenient path to...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

This is where  your work makes a difference. At Baxter, we believe every person—regardless of who they are or where they are from—deserves a chance to live a healthy life. It was our founding belief in 1931 and continues to be our guiding principle. We are redefining healthcare delivery to make a greater impact today, tomorrow, and beyond. Our Baxter colleagues are united by our Mission to Save and Sustain Lives. Together, our community is driven by a culture of courage, trust, and collaboration. Every individual is empowered to take ownership and make a meaningful impact. We strive for efficient and effective operations, and we hold each other accountable for delivering exceptional results. Here, you will find more than just a job—you will find purpose and pride.  The Director, Global Commercial Training & Sales Enablement is responsible for developing and delivering content and tools to train sales professionals on product, selling skills, healthcare market,...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration....

Primary Function of Position: The Endoluminal Director, Japan Sales and Marketing role will guide the company through the pre-commercial phase into product launch and sales of the Ion Endoluminal System in Japan. This role requires a balance of strategic vision and tactical execution, leveraging deep market insights, clinical knowledge, and stakeholder collaboration to drive awareness, adoption, and customer satisfaction. The individual will be responsible for establishing and growing the commercial sales of the Ion Endoluminal system through the recruitment, training and management of a commercial sales and marketing team. This role requires a deep understanding of both front line selling and leading managers to deliver on short-term objectives that will translate into durable long-term performance. A deep understanding of medical device business practices and reimbursement structures in Japan will be necessary to ensure the successful adoption of the Ion Endoluminal System in...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c). Key Account Director As a Key Account Director (KAD) at Madrigal, you will play a vital role in ensuring access to Rezdiffra within assigned regional Integrated Delivery Networks (IDNs) and HCP Super Groups. Working collaboratively across the matrix team, you will execute effective pull-through programs to drive the adoption of Rezdiffra and strengthen relationships with...